Impact of programmed death-ligand 1 expression on the patients of stage IV non-small cell lung cancer harboring epidermal growth factor receptor mutation: a systematic review and meta-analysis.
CONCLUSION: There is low certainty in the evidence to suggest that positive PD-L1 expression is associated with inferior disease control and survival outcomes in patients with stage IV EGFR-mutated NSCLC treated with first-line EGFR TKIs.
PMID: 32835563 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Lee CC, Soon YY, Leong CN, Koh WY, Tey J Tags: Acta Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Lung Cancer | Non-Small Cell Lung Cancer | Study